Literature DB >> 22359255

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

S H Jacobsen1, S C Olesen, C Dirksen, N B Jørgensen, K N Bojsen-Møller, U Kielgast, D Worm, T Almdal, L S Naver, L E Hvolris, J F Rehfeld, B S Wulff, T R Clausen, D L Hansen, J J Holst, S Madsbad.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery causes profound changes in secretion of gastrointestinal hormones and glucose metabolism. We present a detailed analysis of the early hormone changes after RYGB in response to three different oral test meals designed to provide this information without causing side effects (such as dumping).
METHODS: We examined eight obese non-diabetic patients before and within 2 weeks after RYGB. On separate days, oral glucose tolerance tests (25 or 50 g glucose dissolved in 200 mL of water) and a liquid mixed meal test (200 mL 300 kcal) were performed. We measured fasting and postprandial glucose, insulin, C-peptide, glucagon, total and intact glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-2 (GLP-2), peptide YY(3-36) (PYY), cholecystokinin (CCK), total and active ghrelin, gastrin, somatostatin, pancreatic polypeptide (PP), amylin, leptin, free fatty acids (FFA), and registered postprandial dumping. Insulin sensitivity was measured by homeostasis model assessment of insulin resistance.
RESULTS: Fasting glucose, insulin, ghrelin, and PYY were significantly decreased and FFA was elevated postoperatively. Insulin sensitivity increased after surgery. The postprandial response increased for C-peptide, GLP-1, GLP-2, PYY, CCK, and glucagon (in response to the mixed meal) and decreased for total and active ghrelin, leptin, and gastrin, but were unchanged for GIP, amylin, PP, and somatostatin after surgery. Dumping symptoms did not differ before and after the operation or between the tests.
CONCLUSIONS: Within 2 weeks after RYGB, we found an increase in insulin secretion and insulin sensitivity. Responses of appetite-regulating intestinal hormones changed dramatically, all in the direction of reducing hunger.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359255     DOI: 10.1007/s11695-012-0621-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  72 in total

1.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

Review 2.  Gastrins in serum. A review of gastrin radioimmunoanalysis and the discovery of gastrin heterogeneity in serum.

Authors:  J F Rehfeld
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Production and evaluation of antibodies for the radioimmunoassay of gastrin.

Authors:  J F Rehfeld; F Stadil; B Rubin
Journal:  Scand J Clin Lab Invest       Date:  1972-10       Impact factor: 1.713

4.  Plasma glucose after stomach or jejunum glucose infusion in Roux-en-Y gastric bypass patients--a possible implication for early satiety mechanism.

Authors:  L Czupryniak; M Pawłowski; D Szymański; W Olejniczak; M Saryusz-Wolska; J Loba; J Strzelczyk
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-03-03       Impact factor: 2.949

5.  Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms.

Authors:  B Balkan; X Li
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-10       Impact factor: 3.619

6.  The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera.

Authors:  T Krarup; J J Holst
Journal:  Regul Pept       Date:  1984-09

7.  Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

Authors:  R M Elliott; L M Morgan; J A Tredger; S Deacon; J Wright; V Marks
Journal:  J Endocrinol       Date:  1993-07       Impact factor: 4.286

8.  Effects of reconstruction methods on a patient's quality of life after a proximal gastrectomy: subjective symptoms evaluation using questionnaire survey.

Authors:  Masanori Tokunaga; Naoki Hiki; Shigekazu Ohyama; Souya Nunobe; Akira Miki; Tetsu Fukunaga; Yasuyuki Seto; Takeshi Sano; Toshiharu Yamaguchi
Journal:  Langenbecks Arch Surg       Date:  2008-12-10       Impact factor: 3.445

9.  Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report.

Authors:  Carsten Dirksen; Dorte L Hansen; Sten Madsbad; Lisbeth E Hvolris; Lars S Naver; Jens J Holst; Dorte Worm
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939

View more
  111 in total

1.  Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.

Authors:  Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.

Authors:  M S Svane; N B Jørgensen; K N Bojsen-Møller; C Dirksen; S Nielsen; V B Kristiansen; S Toräng; N J Wewer Albrechtsen; J F Rehfeld; B Hartmann; S Madsbad; J J Holst
Journal:  Int J Obes (Lond)       Date:  2016-08-30       Impact factor: 5.095

Review 3.  The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes.

Authors:  Randy J Seeley; Adam P Chambers; Darleen A Sandoval
Journal:  Cell Metab       Date:  2015-02-05       Impact factor: 27.287

4.  Changes in intestinal permeability after Roux-en-Y gastric bypass.

Authors:  Alexandre Lages Savassi-Rocha; Marco Túlio Costa Diniz; Eduardo Garcia Vilela; Maria de Fátima Haueisen Sander Diniz; Soraya Rodrigues de Almeida Sanches; Aloísio Sales da Cunha; Maria de Lourdes de Abreu Ferrari; Henrique Oswaldo da Gama Torres; Bruno Antonio Maciente; Gabriela Santana Ataliba; Paloma Maciel Araújo; Taciana Bretas Guerra; Inara Kellen Fonseca Balbino
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

Review 5.  Hyperinsulinemic hypoglycemia after gastric bypass surgery: what's up and what's down?

Authors:  A Yaqub; E P Smith; M Salehi
Journal:  Int J Obes (Lond)       Date:  2017-10-13       Impact factor: 5.095

6.  Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery.

Authors:  Guilherme M Campos; Charlotte Rabl; Peter J Havel; Madhu Rao; Jean-Marc Schwarz; Morris Schambelan; Kathleen Mulligan
Journal:  Surg Obes Relat Dis       Date:  2013-07-20       Impact factor: 4.734

Review 7.  Bone Health following Bariatric Surgery: Implications for Management Strategies to Attenuate Bone Loss.

Authors:  Tair Ben-Porat; Ram Elazary; Shiri Sherf-Dagan; Ariela Goldenshluger; Ronit Brodie; Yoav Mintz; Ram Weiss
Journal:  Adv Nutr       Date:  2018-03-01       Impact factor: 8.701

8.  Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.

Authors:  M B Mumphrey; L M Patterson; H Zheng; H-R Berthoud
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

9.  Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.

Authors:  Carsten Dirksen; Kirstine N Bojsen-Møller; Nils B Jørgensen; Siv H Jacobsen; Viggo B Kristiansen; Lars S Naver; Dorte L Hansen; Dorte Worm; Jens J Holst; Sten Madsbad
Journal:  Diabetologia       Date:  2013-09-19       Impact factor: 10.122

Review 10.  Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss.

Authors:  Gian Franco Adami; Nicola Scopinaro; Renzo Cordera
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.